RecruitingNot Applicable

Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder

Taiwan30 participantsStarted 2022-08-29

Plain-language summary

This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with somatic symptom disorder (confirmed by psychiatrists) * Age 20-70 Exclusion Criteria: * Having psychotic symptoms or cognitive impairment * Having potentially lethal illness * Using cardiac pacemakers or defibrillators * Currently pregnant or having plans to become pregnant within the next three months * Received rTMS treatment within three months * Cannot read the questionnaires by oneself * Having to take the following medications persistently: bupropion \>300 mg/day、TCA、clozapine、chlorpromazine、foscarnet、ganciclovir、ritonavir、theophylline

What they're measuring

Scores of Patient Health Questionnaire-15 (PHQ-15)

Timeframe: Week 3 (comparing with the data in week 0) of the two sections (rTMS and sham)

Scores of Health Anxiety Questionnaire (HAQ)

Timeframe: Week 3 (comparing with the data in week 0) of the two sections (rTMS and sham)

Trial details

NCT IDNCT05161819

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Wei-Lieh Huang, MD, PhD

886-5-5323911 weiliehhuang@gmail.com

View on ClinicalTrials.gov More Somatic Symptom Disorder trials